Saiqa Mullick

Saiqa Mullick

South Africa South AfricascientistFemale9.0Global Dominance: 0.00%

Professor Saiqa Mullick is a prominent figure in HIV research and prevention, affiliated with the Wits RHI in South Africa. She has been actively involved in advocating for affordable access to HIV prevention methods, highlighting the importance of such treatments for young people and underserved communities. Recently, she spoke on the transformative potential of Lenacapavir, a new HIV prevention injection, following a landmark deal that will make it available at a significantly reduced cost in low- and middle-income countries.

Power2,011
Reach340,855

Country presence

Recent news mentions

Saiqa Mullick is the chief researcher of the LEN4PrEP study.

Bhekisisa analysed SA’s first LEN roll-out data. Here's what it found
Mail & Guardian·South AfricaSouth Africa· 2026-08-03
9.0
Also mentioned
Aaron Motsoaledi
Aaron Motsoaledi

Professor Saiqa Mullick from Wits RHI stated that Lenacapavir had the potential to transform prevention, especially for young people and underserved communities.

Landmark deal paves way for cheaper HIV/ Aids protection jab
BBC·United KingdomUnited Kingdom· 2025-09-24
7.0